Keywords: داروهای عمومی; D12; D60; D90; I11; Doctors; Pharmaceuticals; Prescription drugs; Generic drugs; Welfare;
مقالات ISI داروهای عمومی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروهای عمومی; Pharmaceutical policy; Generic substitution; Generic drugs; Pharmaceutical sales; Japan; Sweden;
Keywords: داروهای عمومی; D40; I13; L13; L65; Price competition; Dynamic; Adjustment; Pharmaceutical industry; Generic drugs; Brand-name drugs; Reference price; Generic substitution;
Keywords: داروهای عمومی; Neuropathic pain; Gabapentin; Brand name drugs; Generic drugs; Adherence; Costs; Age; Sex; Dolor neuropático; Gabapentina; Medicamentos de marca; Genéricos; Adherencia; Costes; Edad; Género;
Keywords: داروهای عمومی; Pharmacoeconomics; Health economics; Generic drugs; Generic pharmaceutical pricing; Reimbursement; Internal reference pricing;
Keywords: داروهای عمومی; Antibiotic resistance; Environmental performance; Generic drugs; Outsourcing; Pharmaceutical production; Transparency;
Keywords: داروهای عمومی; Generic drugs; Drug-device combinations; Bioequivalence; Complex products;
Keywords: داروهای عمومی; Clopidogrel; Generic drugs; Multilevel analysis; Patient access; Pharmaceutical policy;
Keywords: داروهای عمومی; Generic drugs; Purchase intention; Theory of Planned Behaviour; Perceived risk; Brand sensitivity; Trust; Self-identity; Structural equation modelling;
Keywords: داروهای عمومی; Disease-modifying treatments; Generic drugs; Glatiramer acetate; Multiple sclerosis; Copaxone; Glatopa;
Keywords: داروهای عمومی; ATC classification system; content analysis; generic drugs; PubMed/Medline;
Keywords: داروهای عمومی; Brand name drugs; Generic drugs; Price difference; Claims database; Out-of-hospital pharmacies; Logistic regression analysis;
Keywords: داروهای عمومی; Bioequivalence; Antipsychotics; Antidepressants; Generic drugs; Reference drugsbiorównoważność; leki przeciwpsychotyczne; leki przeciwdepresyjne; generyki; leki referencyjne
Keywords: داروهای عمومی; Antiretroviral drugs; Bioequivalence; Generic drugs; Pharmacovigilance; SubstitutionAntirétroviraux; Bioéquivalence; Génériques; Pharmacovigilance; Substitution
Keywords: داروهای عمومی; Generic drugs; Low-income; Health care cost; Health care access
Keywords: داروهای عمومی; Generic drugs; Generics paradox; Attitudes; Generics policy;
Keywords: داروهای عمومی; General practitioners; Pharmacists; Generic drugs; Professional education; Patient education; Health policy; Ireland;
Keywords: داروهای عمومی; Beliefs; Generic drugs; Pharmaceutical policies; Production; Uptake;
Keywords: داروهای عمومی; Epilepsy; Antiepileptic drugs; Generic drugs; Prescribing; Cross-sectional;
Keywords: داروهای عمومی; Pharmaceutical policy; Generic substitution; Generic drugs; Japan; Sweden; 4E
Keywords: داروهای عمومی; Medicine pricing; South Africa; Generic drugs; Single exit price; Price competition
Keywords: داروهای عمومی; Antipsychotics; Antidepressants; Bioequivalence; Generic drugs
Keywords: داروهای عمومی; Generic substitution; Generic drugs; Opinions; Patients; Poland
Keywords: داروهای عمومی; Pharmaceutical regulation; Interest groups; Generic drugs
Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis
Keywords: داروهای عمومی; Medicare; star ratings; quality of care; generic drugs;
Efecto de la edad y el género sobre las consecuencias clÃnicas y económicas del tratamiento con especialidad farmacéutica de marca o genérica en pacientes con dolor neuropático periférico en práctica clÃnica habitual
Keywords: داروهای عمومی; Dolor neuropático; Gabapentina; Medicamentos de marca; Genéricos; Adherencia; Costes; Neuropathic pain; Gabapentin; Brand name drugs; Generic drugs; Adherence; Costs;
Technical challenges in obtaining an optimized powder/DPI combination for inhalation delivery of a bi-component generic drug
Keywords: داروهای عمومی; DPI; Generic drugs; Product development; Inhalation; Fluticasone; Salmeterol; Fluticasone propionate (PubChem CID: 444036); Salmeterol (PubChem CID: 5152); Lactose monohydrate (PubChem CID: 57654326);
Utilization of free medication samples in the United States in a nationally representative sample: 2009-2013
Keywords: داروهای عمومی; Sample medications; Generic drugs; Pharmaceutical marketing; Physician prescribing;
HERA-QUEST: HTA-Evaluation generischer Arzneimittel zur Verbesserung von Qualität, Oekonomie, Patientensicherheit und Transparenz bei Produktumstellungen in Kliniken
Keywords: داروهای عمومی; Generika; HTA (Health Technology Assessment); Patientensicherheit; Qualitätsmanagement; Transparenz; Stationäre Arzneimitteltherapie; generic drugs; HTA (health technology assessment); patient safety; quality management; transparency; inpatient drug the
Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam
Keywords: داروهای عمومی; Therapeutic equivalence; Generic drugs; Animal model; Experimental animal models; Piperacillin/tazobactam
El caso Glivec®: primer ejemplo de debate global en torno al sistema de patentes de medicamentos
Keywords: داروهای عمومی; Descubrimiento de fármacos; Difusión de la innovación; Genéricos; India; Industria farmacéutica; Países del Tercer Mundo; Propiedad intelectualDeveloping countries; Diffusion of innovation; Drug discovery; Generic drugs; India; Intellectual property; Phar
Analyses of marketplace tacrolimus drug product quality: Bioactivity, NMR and LC-MS
Keywords: داروهای عمومی; Drug product quality; Ascomycin; Drug product impurities; Immunosuppression; Generic drugs;
Comparative Effect of Racemic Amlodipine and its Enantiomer with Atenolol on Hypertensive Patients—A Randomized, Open, Parallel Group Study
Keywords: داروهای عمومی; atenolol; generic drugs; hypertension; RS-amlodipine; S-amlodipine
Différences de taux de substitution des médicaments génériques en Midi-Pyrénées en fonction des classes pharmaco-thérapeutiques
Keywords: داروهای عمومی; Médicaments génériques; Substitution; Soins primaires; Generic drugs; Generic substitution; Primary care;
Presencia y adecuación de los principios activos farmacológicos en la edición española de la Wikipedia
Keywords: داروهای عمومی; Wikipedia; Internet; Medicamentos genéricos; Acceso a la información; Diseminación de información; ComunicaciónWikipedia; Internet; Generic drugs; Access to information; Information dissemination; Communication
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
Keywords: داروهای عمومی; Generic drugs; Drug Price Competition and Patent Term Restoration Act; Abbreviated new drug application; Bioequivalence; Drug quality; Generic drug substitution
Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products
Keywords: داروهای عمومی; Generic drugs; Therapeutic equivalency; Bioequivalence; Sustained-release; Single dose; Multiple dose;
Generic drugs: myths, facts, and limitations
Keywords: داروهای عمومی; Bioequivalence; Bioavailability; Generic drugs; Pharmacokinetics;
Generic antibiotic drugs: Is effectiveness guaranteed?
Keywords: داروهای عمومی; Antibiotics; Branded drugs; Effectiveness; Generic drugs; Therapeutic equivalenceAntibiotiques; Médicament princeps; Efficacité; Médicament générique; Équivalence thérapeutique
Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization
Keywords: داروهای عمومی; Pharmaceutical; Competition; Patent; Marketing; Generic drugs; Drug prices;
Generic drug prescriptions following hospital discharge: A prospective study in France
Keywords: داروهای عمومی; Economics; Pharmaceutical; Generic drugs; Brand-name drug; University teaching hospital
Licences obligatoires de médicaments pour les pays connaissant des problèmes de santé publique : mythe ou réalité juridiques ?
Keywords: داروهای عمومی; Médicament; Génériques; Brevet (médicament); Accords ADPIC; Drugs; Generic drugs; Patented drug; Compulsory licensing; TRIPS Agreement;
Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products
Keywords: داروهای عمومی; Generic drugs; Enteric coated tablets; In vitro drug release; Similarity factor; Pantoprazole sodium sesquihydrate
Psychosocial factors associated with the prescription of generic drugs
Keywords: داروهای عمومی; Generic drugs; Drug prescriptions; Psychological models; Family Physicians; Professional practice
Le médicament générique au Maroc : enquête auprès des médecins
Keywords: داروهای عمومی; médicaments génériques; connaissances des médecins; prescription; droit de substitution; generic drugs; knowledge of physicians; prescription; substitution rights;
Competition and the Reference Pricing Scheme for pharmaceuticals
Keywords: داروهای عمومی; I18; L10; L51; L41; Rerence pricing; Pharmaceuticals; Generic drugs; Competition;
Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial
Keywords: داروهای عمومی; ciclosporin; generic drugs; interchangeability; renal transplantation;
Deeply discounted medications: Implications of generic prescription drug wars
Keywords: داروهای عمومی; Chain pharmacy; generic drugs; medication use; adherence (medication); quality of care;
Do generic firms and the Spanish public purchaser respond to consumer price differences of generics under reference pricing?
Keywords: داروهای عمومی; Generic drugs; Price competition; Reference pricing; Pharmaceutical expenditure
Influencia de la sustitución de medicamentos de marca por genéricos en el cumplimiento terapéutico de la hipertensión arterial y la dislipidemia
Keywords: داروهای عمومی; Cumplimiento; Adherencia; Medicamentos genéricos; Sustitución por genéricos; Hipertensión; Dislipidemia; Compliance; Adherence; Generic drugs; Generic substitution; Hypertension; Dyslipidemia;